Pear, VeraLight partner to distribute SCOUT DS device in pharmacies across Canada

VeraLight Inc., the first company to develop an optical skin measurement for noninvasive diabetes screening, and Pear Healthcare Solutions Inc., a leading provider of in-pharmacy health screening and education services, today announced an agreement for the distribution of the SCOUT DS device in pharmacies across Canada.

"Since gaining our Health Canada License Approval and European CE Mark, we have been thrilled with the level of interest in distributing SCOUT DS outside of the United States," said David Van Avermaete, CEO of VeraLight.  "After an extensive review, we chose Pear as our partner to bring the SCOUT DS to Canadian pharmacies based on its track record as a respected provider of high quality testing services and education for consumers on behalf of pharmacies, pharmaceutical and device companies."

"We at Pear Healthcare Solutions are proud to have been selected by VeraLight as its first distribution and education partner," said Mark Doyle, Vice President of Sales and Marketing for Pear. "I am confident that by providing this technology to Canadian pharmacies, we can make a positive difference in the healthcare system and in people's lives.  The potential to identify people with undiagnosed diabetes or prediabetes could reduce long-term healthcare costs and improve the quality of lives for Canadians. We will introduce the device with screening events in two pharmacies in Ontario in August and expand across the country in the coming months."